XML 76 R63.htm IDEA: XBRL DOCUMENT v2.4.0.8
Shareholders' Equity (Details) (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total share-based compensation costs included in consolidated net loss (in dollars) $ 11,746,000 $ 7,551,000 $ 4,911,000
Weighted Average Grant Date Fair Value      
Common stock reserved for share-based awards outstanding and available future grants 16,305,984    
Continuing operations
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total share-based compensation costs included in consolidated net loss (in dollars) 11,746,000 7,282,000 4,540,000
Discontinued operations
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total share-based compensation costs included in consolidated net loss (in dollars) 0 269,000 371,000
Non-employee directors
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total share-based compensation costs included in consolidated net loss (in dollars) 558,000 517,000 349,000
RSUs
     
Number of RSUs      
Nonvested shares outstanding at the beginning of the period (in shares) 1,685,000    
Granted (in shares) 3,244,000    
Vested (in shares) (1,770,000)    
Forfeited (in shares) (410,000)    
Nonvested shares outstanding at the end of the period (in shares) 2,749,000 1,685,000  
Weighted Average Grant Date Fair Value      
Nonvested shares outstanding at the beginning of the period (in dollars per share) $ 4.43    
Granted (in dollars per share) $ 4.12    
Vested (in dollars per share) $ 4.29    
Forfeited (in dollars per share) $ 4.06    
Nonvested shares outstanding at the end of the period (in dollars per share) $ 4.09 $ 4.43  
Total fair value (in dollars) 6,800,000 2,900,000 2,800,000
Total unrecognized compensation cost (in dollars) 9,300,000    
Weighted average period for recognition of unrecognized stock-based compensation expense 2 years 0 months 4 days    
RSUs | Minimum
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period 1 year    
RSUs | Maximum
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period 3 years    
RSUs | Non-employee directors
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Value of common stock granted initial grant 100,000    
Value of common stock granted annual grant 100,000    
RSUs | Non-employee directors | Initial grant
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period 3 years    
RSUs | Non-employee directors | Annual grant
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting period 1 year    
Stock option
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Contractual terms 10 years    
Weighted average assumptions used to value options granted and the grant date fair value      
Expected life (in years)   4 years 4 months 24 days 4 years 2 months 12 days
Risk-free interest rate   0.63% 1.34%
Expected volatility   70.00% 67.00%
Dividend yield   0.00% 0.00%
Fair value   $ 2.13 $ 2.55
Number of Options      
Outstanding at the beginning of the period (in shares) 8,115,000    
Granted (in shares) 0    
Exercised (in shares) (635,000)    
Expired or cancelled (in shares) (1,801,000)    
Forfeited (in shares) (302,000)    
Outstanding at the end of the period (in shares) 5,377,000 8,115,000  
Vested and expected to vest at the end of the period (in shares) 5,336,000    
Exercisable at the end of the period (in shares) 4,375,000    
Weighted Average Exercise Price      
Outstanding at the beginning of the period (in dollars per share) $ 4.58    
Granted (in dollars per share) $ 0.00    
Exercised (in dollars per share) $ 3.43    
Expired or canceled (in dollars per share) $ 6.00    
Forfeited (in dollars per share) $ 4.42    
Outstanding at the end of the period (in dollars per share) $ 4.33 $ 4.58  
Vested and expected to vest at the end of the period (in dollars per share) $ 4.34    
Exercisable at the end of the period (in dollars per share) $ 4.55    
Weighted Average Remaining Contractual Term      
Outstanding at the end of the period 3 years 2 months 19 days    
Vested and expected to vest at the end of the period 3 years 2 months 9 days    
Exercisable at the end of the period 2 years 10 months 10 days    
Aggregate Intrinsic Value      
Outstanding at the end of the period 3,500,000    
Vested and expected to vest at the end of period 3,469,000    
Exercisable at the end of the period 2,682,000    
Total intrinsic value of options exercised 500,000 300,000 2,100,000
Stock option | Maximum
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Contractual terms 10 years    
2004 Plan
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares of common stock authorized for issuance 20,350,000    
Number of share available for future grants 8,180,639    
2004 Plan | Stock option | Minimum
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Contractual terms 4 years    
Contractual terms for awards granted during last three fiscal years 5 years    
2004 Plan | Stock option | Maximum
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Contractual terms 10 years    
Expiration term 10 years    
Contractual terms for awards granted during last three fiscal years 7 years    
ESPP
     
Weighted Average Grant Date Fair Value      
Contribution of compensation by the employees per calendar year, percentage 10.00%    
Contribution of compensation by the employees per calendar year $ 10,000    
Percentage of the discount fair market value of common stock 95.00%    
Offering period 3 months    
Number of shares issued 206,000 281,000 442,000